SkåneÖrnen AB
5 of 20 shown
The 5 most recent of 20 visible filings, newest first.
- PharmaLundensis AB Chief executive officer96,143 SEKOpen-market buy
- PharmaLundensis AB Chief executive officer19,748 SEKOpen-market buy
- PharmaLundensis AB Chief executive officer29,610 SEKOpen-market buy
- PharmaLundensis AB Chief executive officer22,801 SEKOpen-market buy
- PharmaLundensis AB Chief executive officer21,080 SEKOpen-market buy